iShares Biotechnology ETF (IBB)
211.92
-1.89
(-0.88%)
USD |
NASDAQ |
Sep 04, 16:00
209.12
-2.80
(-1.32%)
Pre-Market: 09:20
Price Chart
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.44% | 0.00% | 10.73B | 1.509M |
| Weighted Average Dividend Yield | Turnover Ratio (Generic) | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| 0.46% | 27.00% | 1.658B |
Basic Info
| Investment Strategy | |
| The Fund seeks to track the investment results of the ICE Biotechnology Index, which measures the performance of US-listed securities of companies that are classified within the Biotechnology Sub-Industry Group. The Fund generally invests at least 90% of its assets in securities of the Underlying Index. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Multi Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | BlackRock |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of September 08, 2026.
Asset Allocation
As of July 31, 2026.
| Type | % Net |
|---|---|
| Cash | -0.24% |
| Stock | 99.92% |
| Bond | 0.35% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | -0.03% |
Basic Info
| Investment Strategy | |
| The Fund seeks to track the investment results of the ICE Biotechnology Index, which measures the performance of US-listed securities of companies that are classified within the Biotechnology Sub-Industry Group. The Fund generally invests at least 90% of its assets in securities of the Underlying Index. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Multi Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | BlackRock |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |